CBTCannabitriol
A triol of the THC series (9,10-dihydroxy-Δ6a(10a)-THC), a minor constituent of cannabis; no measured pharmacology.
C₂₁H₃₀O₄
CAS 11003-36-4
- Family
- PhytocannabinoidMinor
- Origin
- Degradation product
- Molar mass
- 346.50 g/mol
Updated on
In plain terms
Cannabitriol (CBT) is a minor cannabinoid of cannabis, first reported in 1966 in Japanese hemp. It is described as a degradation product of THC. No laboratory study has measured its action on the body's receptors.
Receptors and activity
Pharmacology
Cannabitriol (CBT, 9,10-dihydroxy-Δ6a(10a)-tetrahydrocannabinol) was reported in 1966 in Japanese hemp by Obata and Ishikawa; its structure was established in 1976 (Chan et al.) and the configuration of its two pairs of enantiomers by X-ray diffraction of (±)-trans-cannabitriol in 1984 (Radwan 2021). The CBT type groups nine compounds isolated from cannabis, including (−)-trans-CBT, (+)-trans-CBT, isolated in 1977 by ElSohly et al., and (±)-cis-CBT; two ethoxy derivatives are regarded as artefacts of ethanol extraction (Radwan 2021). Russo et al. (2008) detected it by gas chromatography in funerary cannabis about 2 700 years old, describing it as a degradation product of THC. No in vitro measurement at the cannabinoid receptors was found; the only pharmacological datum is a virtual-screening prediction at the oestrogen receptor ERα, not confirmed experimentally (Caprioglio 2022). Not to be confused with cannabicitran, which some sources also abbreviate « CBT ».
Key sources.
- Obata & Ishikawa 1966, Agric Biol Chem 30:619: Gibbs-positive compound from Japanese hemp (new tab)DOI 10.1080/00021369.1966.10858651
- Chan, Magnus & Watson 1976, Experientia: structure of cannabitriol (new tab)PMID 1253891
- ElSohly, El-Feraly & Turner 1977, Lloydia: (+)-cannabitriol and 10-ethoxy derivative (new tab)PMID 895385
- Radwan et al. 2021, Molecules: CBT type (new tab)PMID 34066753
- Russo et al. 2008, J Exp Bot: 2,700-year-old funerary cannabis (new tab)PMID 19036842
- Caprioglio et al. 2022, Biomolecules: ERα virtual screening, to be confirmed (new tab)PMID 36008978
- ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (benzo[c]chromene class) (new tab)
History
- Source
- Present in cannabis as a degradation product (described as derived from THC); isolated in enantiomeric and racemic forms
Biosynthetic pathway
No known enzymatic pathway. Russo et al. (2008) describe it as a degradation product of THC; no study of the mechanism was found. Natural cannabitriol has been isolated as the (−)-trans, (+)-trans and (±)-cis forms, and its two ethoxy derivatives are regarded as artefacts of ethanol extraction (Radwan 2021).
Legal framework
- European Union
No EU instrument specific to the molecule. Not named in the schedules of the 1961 and 1971 United Nations conventions, according to annexes I to III of the ANSM consolidated list (26/06/2026). Checked 20/10/2026.
- France
Cannabitriol is not named in the ANSM consolidated list (updated 26/06/2026). It is a derivative of the benzo[c]chromene nucleus carrying the substituents listed in the generic class of the ANSM decisions of 22/05/2024 and 03/06/2024 (hydroxyl at 1, pentyl chain at 3, two methyls at 6, methyl at 9), but also two hydroxyls, at 9 and 10, which the definition does not mention; it is not among the exclusions (CBN, CBNA, THCV and THCVA up to 0.3 %, THCA subject to content). Whether it falls within the class is a matter of legal interpretation. Checked 20/10/2026.
Sources: EUR-Lex, UNODC, CND, ANSM, IUPHAR/BPS, ChEBI, EUDA. Our method.
Classification
Family, origin and source verification
- Family
Phytocannabinoid › Minor
- Presence in the plant
Artefact: formed by oxidation, light, heat or solvent
- Chemistry
Type CBT · C5 side chain · neutral form
- Verification
Checked on 20 October 2026; some points still await human review.
- Wikipedia (English)
Article paired by the molecule's structure (InChIKey), revision read on 19 October 2026. Read as a second opinion, never cited as a source.
References
- Obata & Ishikawa 1966, Agric Biol Chem 30:619: Gibbs-positive compound from Japanese hemp (new tab)DOI 10.1080/00021369.1966.10858651
- Chan, Magnus & Watson 1976, Experientia: structure of cannabitriol (new tab)PMID 1253891
- ElSohly, El-Feraly & Turner 1977, Lloydia: (+)-cannabitriol and 10-ethoxy derivative (new tab)PMID 895385
- Radwan et al. 2021, Molecules: CBT type (new tab)PMID 34066753
- Russo et al. 2008, J Exp Bot: 2,700-year-old funerary cannabis (new tab)PMID 19036842
- Caprioglio et al. 2022, Biomolecules: ERα virtual screening, to be confirmed (new tab)PMID 36008978
- ANSM, consolidated list of substances classified as narcotics, updated 26/06/2026 (benzo[c]chromene class) (new tab)
Identifiers
Names
- Common name
- Cannabitriol
- IUPAC name
- 6,6,9-trimethyl-3-pentyl-8,10-dihydro-7H-benzo[c]chromene-1,9,10-triol
- Other names
- CBT · CBT-C5 · 9,10-dihydroxy-Δ6a(10a)-THC
Identifiers
- Formula
- C₂₁H₃₀O₄
- CAS
- 11003-36-4
- PubChem CID
- 11551959(new tab)
- InChIKey
- ZLYNXDIDWUWASO-UHFFFAOYSA-N
- SMILES
- CCCCCC1=
CC(= C2C(= C1) OC(C3= C2C(C(CC3) (C) O) O) (C) C) O
LLM ingestion format: a structured superset of the entry (identifiers, binding, versioned legal status). Full corpus.